Alan Solinger

Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized,…

Journal of Allergy and Clinical Immunology · 2015 · 208 citations

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

Annals of the Rheumatic Diseases · 2012 · Last of 8 authors · 183 citations